GlassScriptPhysician profile
Benjamin Andrew Rauh
NPI 1467947481
$2,003.34
in general payments reported to CMS, 2019-2025
27 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $44.31 · 2022: $177 · 2023: $604 · 2024: $596 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,442 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,441.58 |
| Education | $144.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.24 | 2019-2025 | |
| Astellas Pharma US INC | $190.01 | 2023-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $185.97 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $175.29 | 2022-2025 | |
| Aspira Women'S Health INC | $129.73 | 2019-2020 | |
| Myriad Women'S Health, INC. | $126.18 | 2023 | Myrisk |
| Shield Therapeutics INC | $103.61 | 2023-2025 | Accrufer |
| Millicent US INC | $99.69 | 2023-2025 | Intrarosa, Femlyv |
| Hologic Sales and Service, LLC | $96.27 | 2022-2024 | Aptima, Acessa Provu System, Myosure Tissue Removal Device |
| Intuitive Surgical, INC. | $93.81 | 2022-2025 | |
| Sage Therapeutics, LLC | $64.62 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $62.09 | 2023-2025 | Myfembree |
| Organon LLC | $56.60 | 2023-2025 | Nexplanon |
| Ethicon US, LLC | $52.38 | 2023-2025 | Harmonic, Enseal, Surgiflo Hemostatic Matrix |
| Exeltis, USA INC. | $46.18 | 2023-2025 | Slynd |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $35.87 | 2022 | |
| Pfizer INC. | $26.30 | 2025 | |
| Conmed Corporation | $25.14 | 2024 | Airseal, Visiclear |
| Merck Sharp & Dohme LLC | $18.62 | 2019 | |
| Monaghan Medical Corporation | $18.35 | 2023 | Aerochamber |
| Amag Pharmaceuticals, INC. | $18.10 | 2019 | |
| Supernus Pharmaceuticals, INC. | $17.17 | 2025 | Qelbree |
| Convatec INC. | $16.91 | 2024 | |
| Lilly USA, LLC | $15.62 | 2024 | Zepbound |
| Evofem Biosciences, INC. | $14.82 | 2022 | |
| Agile Therapeutics, INC. | $13.97 | 2023 | Twirla |
| Lsi Solutions INC | $12.80 | 2023 | Running Device, Fornisee, Ti Knot |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Rauh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.